The rare anaphylaxis-associated FcgammaRIIa3 exhibits distinct characteristics from the canonical FcgammaRIIa1
Journal Title
Frontiers in Immunology
Publication Type
Journal Article
Abstract
FcgammaRIIa is an activating FcgammaR, unique to humans and non-human primates. It induces antibody-dependent proinflammatory responses and exists predominantly as FcgammaRIIa1. A unique splice variant, we designated FcgammaRIIa3, has been reported to be associated with anaphylactic reactions to intravenous immunoglobulins (IVIg) therapy. We aim to define the functional consequences of this FcgammaRIIa variant associated with adverse responses to IVIg therapy and evaluate the frequency of associated SNPs. FcgammaRIIa forms from macaque and human PBMCs were investigated for IgG-subclass specificity, biochemistry, membrane localization, and functional activity. Disease-associated SNPs were analyzed by sequencing genomic DNA from 224 individuals with immunodeficiency or autoimmune disease. FcgammaRIIa3 was identified in macaque and human PBMC. The FcgammaRIIa3 is distinguished from the canonical FcgammaRIIa1 by a unique 19-amino acid cytoplasmic insertion and these two FcgammaRIIa forms responded distinctly to antibody ligation. Whereas FcgammaRIIa1 was rapidly internalized, FcgammaRIIa3 was retained longer at the membrane, inducing greater calcium mobilization and cell degranulation. Four FCGR2A SNPs were identified including the previously reported intronic SNP associated with anaphylaxis, but in only 1 of 224 individuals. The unique cytoplasmic element of FcgammaRIIa3 delays internalization and is associated with enhanced cellular activation. The frequency of the immunodeficiency-associated SNP varies between disease populations but interestingly occurred at a lower frequency than previously reported. None-the-less enhanced FcgammaRIIa3 function may promote a proinflammatory environment and predispose to pathological inflammatory responses.
Publisher
Frontiers Media
Research Division(s)
Immunology
PubMed ID
30177930
Open Access at Publisher's Site
https://doi.org/10.3389/fimmu.2018.01809
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2018-09-06 03:45:13
Last Modified: 2018-09-07 11:28:21
An error has occurred. This application may no longer respond until reloaded. Reload 🗙